(-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
Background: Aberrant chronic inflammation and excess accumulation of lipids play a pivotal role in the occurrence and progression of atherosclerosis. (-)-Epigallocatechin-3-gallate (EGCG), the major catechins in green tea, displayed anti-atherosclerotic properties in vivo and in vitro. However, the...
Saved in:
Main Authors: | Wei Wang (Author), Zheng-Zhu Zhang (Author), Yan Wu (Author), Ru-Qing Wang (Author), Jin-Wu Chen (Author), Jing Chen (Author), Yan Zhang (Author), Ya-Jun Chen (Author), Ming Geng (Author), Zhong-Dong Xu (Author), Min Dai (Author), Jin-Hua Li (Author), Li-Long Pan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
by: Wei Wang, et al.
Published: (2018) -
Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
by: Qianjin Xie, et al.
Published: (2021) -
Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
by: Xiaoguang Li, et al.
Published: (2017) -
Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells
by: Zhang J, et al.
Published: (2019) -
Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales
by: Yang Qu, et al.
Published: (2023)